DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Type I diabetes mellitus	R-HSA-5683209	map04940	thiamazole	1349907	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	lithocholic acid	3516	drug-path
Olfactory transduction	R-HSA-9751605	map04740	lithocholic acid	3516	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	lithocholic acid	3516	drug-path
Asthma	R-HSA-444620	map05310	lithocholic acid	3516	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	lithocholic acid	3516	drug-path
Allograft rejection	R-HSA-9679028	map05330	lithocholic acid	3516	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	lithocholic acid	3516	drug-path
Homologous recombination	R-HSA-5685942	map03440	lithocholic acid	3516	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	lithocholic acid	3516	drug-path
Pathways in cancer	R-HSA-9824443	map05200	lithocholic acid	3516	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	lithocholic acid	3516	drug-path
Glioma	Q9NZM4	map05214	nalidixic acid	9903	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	nalidixic acid	9903	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	nalidixic acid	9903	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	nalidixic acid	9903	drug-path
Olfactory transduction	R-HSA-9751605	map04740	nalidixic acid	9903	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	nalidixic acid	9903	drug-path
ErbB signaling pathway	R-HSA-168638	map04012	nalidixic acid	9903	drug-path
Asthma	R-HSA-444620	map05310	nalidixic acid	9903	drug-path